FAM64A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.865600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.864200E-01
Normal-vs-Stage2
3.611400E-01
Normal-vs-Stage3
6.495000E-01
Normal-vs-Stage4
7.635200E-01
Stage1-vs-Stage2
2.583400E-01
Stage1-vs-Stage3
6.674800E-01
Stage1-vs-Stage4
8.957600E-01
Stage2-vs-Stage3
6.490600E-01
Stage2-vs-Stage4
4.143600E-01
Stage3-vs-Stage4
7.684000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.050000E-01
Normal-vs-AfricanAmerican
4.095200E-01
Normal-vs-Asian
9.925600E-02
Caucasian-vs-AfricanAmerican
9.933400E-01
Caucasian-vs-Asian
6.462600E-01
AfricanAmerican-vs-Asian
8.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.071200E-01
Normal-vs-Female
3.717000E-01
Male-vs-Female
3.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.674000E-01
Normal-vs-Age(41-60Yrs)
3.266200E-01
Normal-vs-Age(61-80Yrs)
4.347200E-01
Normal-vs-Age(81-100Yrs)
2.439600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.503360E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.506220E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.044030E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.483800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.592200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.638650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.195200E-01
Normal-vs-Daily Drinker
4.015200E-01
Normal-vs-Weekly Drinker
4.166400E-01
Normal-vs-Occasional Drinker
2.830000E-01
Normal-vs-Social Drinker
3.884600E-01
Non Drinker-vs-Daily Drinker
7.178400E-01
Non Drinker-vs-Weekly Drinker
3.081200E-01
Non Drinker-vs-Occasional Drinker
1.487590E-01
Non Drinker-vs-Social Drinker
4.606600E-01
Daily Drinker-vs-Weekly Drinker
4.019200E-01
Daily Drinker-vs-Occasional Drinker
2.761200E-01
Daily Drinker-vs-Social Drinker
6.697600E-01
Weekly Drinker-vs-Occasional Drinker
8.998000E-01
Weekly Drinker-vs-Social Drinker
5.887200E-01
Occasional Drinker-vs-Social Drinker
5.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.692800E-01
Normal-vs-Grade 2
6.203200E-01
Normal-vs-Grade 3
6.464400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.803700E-03
Grade 1-vs-Grade 3
4.760100E-04
Grade 1-vs-Grade 4
5.692800E-01
Grade 2-vs-Grade 3
2.105600E-01
Grade 2-vs-Grade 4
6.203200E-01
Grade 3-vs-Grade 4
6.464400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.344600E-01
Normal-vs-NonDiabetic
3.162200E-01
Diabetic-vs-NonDiabetic
4.822000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.869800E-02
Normal-vs-NoPancreatitis
4.210400E-01
Pancreatitis-vs-NoPancreatitis
1.829810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.675800E-01
Normal-vs-N1
4.122400E-01
N0-vs-N1
6.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.412600E-04
Normal-vs-TP53-NonMutant
5.340400E-01
TP53-Mutant-vs-TP53-NonMutant
1.36029999997511E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
